Silicon Laboratories (SLAB) FY2020 results: revenue $511 million, up 7.8% on the year
Silicon Laboratories Inc. (SLAB) reported revenue of $511 million for fiscal 2020, the year ended 2 January 2021, up 7.8% on the year before. Net income was $13 million, down 35.0%, and diluted earnings per share $0.28. The figures are the company's own, from the 10-K it filed with the SEC on 3 February 2021.
Revenue
$511 million
+7.8% on the year
FY2013FY2020
Operating margin
-21.0%
-18.7% a year earlier
FY2013FY2020
Net income
$13 million
-35.0% on the year
FY2013FY2020
Diluted EPS
$0.28
-34.9% on the year
FY2013FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
511
474
868
+7.8%
Cost of revenue
216
194
347
+11.6%
Gross profit
295
280
521
+5.2%
Gross margin
57.7%
59.1%
60.1%
Research and development
235
206
238
+14.3%
Selling, general and administrative
167
163
198
+2.2%
Operating income
-107
-88.6
85.2
Operating margin
-21.0%
-18.7%
9.8%
Interest expense
34.1
20.2
19.7
+68.7%
Pre-tax income
-130
-96.0
72.2
Income tax
-14.6
7.0
-11.4
Effective tax rate
n/a
n/a
-15.8%
Net income
12.5
19.3
83.6
-35.0%
Net margin
2.5%
4.1%
9.6%
Diluted EPS
$0.28
$0.43
$1.90
-34.9%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
136
167
174
-18.5%
Capital expenditure
18.1
15.3
24.5
+18.2%
Free cash flow
118
151
149
-22.2%
Free cash flow margin
23.0%
31.9%
17.2%
Cash from investing
-361
-107
-197
Cash from financing
201
-29.6
-48.8
Depreciation and amortisation
58.8
52.9
53.9
+11.2%
Share-based compensation
49.5
44.3
50.1
+11.5%
Buybacks
16.3
26.7
39.3
-39.0%
Diluted shares, weighted
44m
44m
44m
+0.2%
Shares outstanding at period end
44m
43m
43m
+1.0%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
1,200
1,115
1,067
+7.6%
Debt
563
368
355
+53.0%
Other liabilities
230
192
202
+20.2%
Total liabilities and equity
1,993
1,675
1,624
+19.0%
Fixed assets
136
136
139
-0.1%
Goodwill
376
237
397
+58.6%
Intangible assets
163
134
171
+21.7%
Investments
522
499
417
+4.6%
Cash and equivalents
203
227
197
-10.8%
Receivables
95.2
75.6
73.2
+25.8%
Inventory
47.9
73.1
75.0
-34.5%
Other assets
450
293
155
+53.8%
Total assets
1,993
1,675
1,624
+19.0%
10-K for the year ended 2 January 2021, filed 3 February 2021: the filing.